Cited by

• Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis.

  Suliman S, Thompson EG, Sutherland J, Weiner J 3rd, Ota MOC, Shankar S, Penn-Nicholson A, Thiel B, Erasmus M, Maertzdorf J, Duffy FJ, Hill PC, Hughes EJ, Stanley K, Downing K, Fisher ML, Valvo J, Parida SK, van der Spuy G, Tromp G, Adetifa IMO, Donkor S, Howe R, Mayanja-Kizza H, Boom WH, Dockrell HM, Ottenhoff THM, Hatherill M, Aderem A, Hanekom WA, Scriba TJ, Kaufmann SHE, Zak DE, Walzl G; GC6-74 cohort study team, The ACS cohort study team. Suliman S, et al. Am J Respir Crit Care Med. 2018 May 1;197(9):1198-1208. doi: 10.1164/rccm.201711-2340OC. Am J Respir Crit Care Med. 2018. PMID: 29624071 Free PMC article.
• Defining a migrant-inclusive tuberculosis research agenda to end TB.

  Shete PB, Boccia D, Dhavan P, Gebreselassie N, Lönnroth K, Marks S, Matteelli A, Posey DL, van der Werf MJ, Winston CA, Lienhardt C. Shete PB, et al. Int J Tuberc Lung Dis. 2018 Aug 1;22(8):835-843. doi: 10.5588/ijtld.17.0503. Int J Tuberc Lung Dis. 2018. PMID: 29991390 Free PMC article. Review.
• Blood RNA signatures predict recent tuberculosis exposure in mice, macaques and humans.

  Ault RC, Headley CA, Hare AE, Carruthers BJ, Mejias A, Turner J. Ault RC, et al. Sci Rep. 2020 Oct 9;10(1):16873. doi: 10.1038/s41598-020-73942-z. Sci Rep. 2020. PMID: 33037303 Free PMC article.
• The Role of Type I Interferons in Tuberculosis and in Tuberculosis-Risk-Associated Comorbidities.

  Mutua F, Su RC, Ball TB, Kiazyk S. Mutua F, et al. Infect Dis Rep. 2025 Jul 8;17(4):81. doi: 10.3390/idr17040081. Infect Dis Rep. 2025. PMID: 40700327 Free PMC article. Review.
• A structural and metabolic framework for classifying pre-clinical tuberculosis infection phenotypes using 18F-FDG PET-CT: a prospective cohort analysis following M. tuberculosis exposure.

  Kim JW, Vadera S, Sharifpour M, Bajaj A, Kamil A, Haldar P. Kim JW, et al. Thorax. 2024 Nov 14;79(12):1156-1159. doi: 10.1136/thorax-2024-221470. Thorax. 2024. PMID: 38914470 Free PMC article.